Therapeutic implications of curcumin in the prevention of diabetic retinopathy via modulation of anti-oxidant activity and genetic pathways
- PMID: 24379904
- PMCID: PMC3867697
Therapeutic implications of curcumin in the prevention of diabetic retinopathy via modulation of anti-oxidant activity and genetic pathways
Abstract
Diabetic Retinopathy (DR) is one of the most common complications of diabetes mellitus that affects the blood vessels of the retina, leading to blindness. The current approach of treatment based on anti-inflammatory, anti-angiogenesis drugs and laser photocoagulation are effective but also shows adverse affect in retinal tissues and that can even worsen the visual abilities. Thus, a safe and effective mode of treatment is needed to control or delaying the DR. Based on the earlier evidence of the potentiality of natural products as anti-oxidants, anti-diabetic and antitumor, medicinal plants may constitute a good therapeutic approach in the prevention of DR. Curcumin, constituents of dietary spice turmeric, has been observed to have therapeutic potential in the inhibition or slow down progression of DR. In this review, we summarize the therapeutic potentiality of curcumin in the delaying the DR through antioxidant, anti-inflammatory, inhibition of Vascular Endothelial Growth and nuclear transcription factors. The strength of involvement of curcumin in the modulation of genes action creates a strong optimism towards novel therapeutic strategy of diabetic retinopathy and important mainstay in the management of diabetes and its complications DR.
Keywords: Medicinal plants; VEGF and diabetic retinopathy; curcumin.
Figures




Similar articles
-
Therapeutic potential of curcumin in diabetic retinopathy (Review).Int J Mol Med. 2021 May;47(5):75. doi: 10.3892/ijmm.2021.4908. Epub 2021 Mar 11. Int J Mol Med. 2021. PMID: 33693955 Free PMC article. Review.
-
Discussing pathologic mechanisms of Diabetic retinopathy & therapeutic potentials of curcumin and β-glucogallin in the management of Diabetic retinopathy.Biomed Pharmacother. 2023 Dec 31;169:115881. doi: 10.1016/j.biopha.2023.115881. Epub 2023 Nov 19. Biomed Pharmacother. 2023. PMID: 37989030 Review.
-
VEGF-targeting drugs for the treatment of retinal neovascularization in diabetic retinopathy.Ann Med. 2022 Dec;54(1):1089-1111. doi: 10.1080/07853890.2022.2064541. Ann Med. 2022. PMID: 35451900 Free PMC article. Review.
-
The Evolving Treatment of Diabetic Retinopathy.Clin Ophthalmol. 2020 Mar 4;14:653-678. doi: 10.2147/OPTH.S236637. eCollection 2020. Clin Ophthalmol. 2020. PMID: 32184554 Free PMC article. Review.
-
Strategies to Tackle the Global Burden of Diabetic Retinopathy: From Epidemiology to Artificial Intelligence.Ophthalmologica. 2020;243(1):9-20. doi: 10.1159/000502387. Epub 2019 Aug 13. Ophthalmologica. 2020. PMID: 31408872 Review.
Cited by
-
Live-cell imaging approaches for the investigation of xenobiotic-induced oxidant stress.Biochim Biophys Acta. 2016 Dec;1860(12):2802-15. doi: 10.1016/j.bbagen.2016.05.017. Epub 2016 May 18. Biochim Biophys Acta. 2016. PMID: 27208426 Free PMC article. Review.
-
Oxidative stress and diabetic retinopathy: Molecular mechanisms, pathogenetic role and therapeutic implications.Redox Biol. 2020 Oct;37:101799. doi: 10.1016/j.redox.2020.101799. Epub 2020 Nov 13. Redox Biol. 2020. PMID: 33248932 Free PMC article. Review.
-
Curcumin, inflammation, and chronic diseases: how are they linked?Molecules. 2015 May 20;20(5):9183-213. doi: 10.3390/molecules20059183. Molecules. 2015. PMID: 26007179 Free PMC article. Review.
-
Curcumin Inhibits Neuronal Loss in the Retina and Elevates Ca²⁺/Calmodulin-Dependent Protein Kinase II Activity in Diabetic Rats.J Ocul Pharmacol Ther. 2015 Nov;31(9):555-62. doi: 10.1089/jop.2015.0006. Epub 2015 Jul 24. J Ocul Pharmacol Ther. 2015. PMID: 26207889 Free PMC article.
-
Systemic Reduction of Glut1 Normalizes Retinal Dysfunction, Inflammation, and Oxidative Stress in the Retina of Spontaneous Type 2 Diabetic Mice.Am J Pathol. 2023 Jul;193(7):927-938. doi: 10.1016/j.ajpath.2023.04.003. Epub 2023 Apr 14. Am J Pathol. 2023. PMID: 37062410 Free PMC article.
References
-
- King H, Aubert RE, Herman WH. Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998;21:1414–1431. - PubMed
-
- Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–1053. - PubMed
Publication types
LinkOut - more resources
Full Text Sources